202 related articles for article (PubMed ID: 34717680)
1. Prospective superficial EPR in-vivo dosimetry study during hypofractionated radiotherapy of breast cancer patients treated with helical tomotherapy.
Höfel S; Gandalini M; Fix MK; Drescher M; Zwicker F
Radiat Oncol; 2021 Oct; 16(1):209. PubMed ID: 34717680
[TBL] [Abstract][Full Text] [Related]
2. Suitability of superficial electron paramagnetic resonance dosimetry for in vivo measurement and verification of cumulative total doses during IMRT: A proof of principle.
Höfel S; Fix MK; Drescher M; Zwicker F
Z Med Phys; 2021 Nov; 31(4):365-377. PubMed ID: 34210537
[TBL] [Abstract][Full Text] [Related]
3. Effect of dose constraint on the thyroid gland during locoregional intensity-modulated radiotherapy in breast cancer patients.
Haciislamoglu E; Canyilmaz E; Gedik S; Aynaci O; Serdar L; Yoney A
J Appl Clin Med Phys; 2019 Jul; 20(7):135-141. PubMed ID: 31231982
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric Evaluation of Different Intensity-Modulated Radiotherapy Techniques for Breast Cancer After Conservative Surgery.
Zhang F; Wang Y; Xu W; Jiang H; Liu Q; Gao J; Yao B; Hou J; He H
Technol Cancer Res Treat; 2015 Oct; 14(5):515-23. PubMed ID: 25311257
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated breast and chest wall irradiation using simultaneous in-field boost IMRT delivered via helical tomotherapy.
Rong Y; Fahner T; Welsh JS
Technol Cancer Res Treat; 2008 Dec; 7(6):433-9. PubMed ID: 19044322
[TBL] [Abstract][Full Text] [Related]
6. Deep inspiration breath-hold intensity modulated radiation therapy in a large clinical series of 239 left-sided breast cancer patients: a dosimetric analysis of organs at risk doses and clinical feasibility from a single center experience.
Testolin A; Ciccarelli S; Vidano G; Avitabile R; Dusi F; Alongi F
Br J Radiol; 2019 Sep; 92(1101):20190150. PubMed ID: 31265316
[TBL] [Abstract][Full Text] [Related]
7. Planning with intensity-modulated radiotherapy and tomotherapy to modulate dose across breast to reflect recurrence risk (IMPORT High trial).
Donovan EM; Ciurlionis L; Fairfoul J; James H; Mayles H; Manktelow S; Raj S; Tsang Y; Tywman N; Yarnold J; Coles C
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1064-72. PubMed ID: 20605349
[TBL] [Abstract][Full Text] [Related]
8. Helical tomotherapy planning for left-sided breast cancer patients with positive lymph nodes: comparison to conventional multiport breast technique.
Goddu SM; Chaudhari S; Mamalui-Hunter M; Pechenaya OL; Pratt D; Mutic S; Zoberi I; Jeswani S; Powell SN; Low DA
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1243-51. PubMed ID: 19251096
[TBL] [Abstract][Full Text] [Related]
9. Investigation of helical tomotherapy for partial-breast irradiation of prone-positioned patients.
Kainz K; White J; Herman J; Li XA
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):275-82. PubMed ID: 19362247
[TBL] [Abstract][Full Text] [Related]
10. Electron paramagnetic resonance (EPR) dosimetry using lithium formate in radiotherapy: comparison with thermoluminescence (TL) dosimetry using lithium fluoride rods.
Vestad TA; Malinen E; Olsen DR; Hole EO; Sagstuen E
Phys Med Biol; 2004 Oct; 49(20):4701-15. PubMed ID: 15566169
[TBL] [Abstract][Full Text] [Related]
11. Effects of megavoltage computed tomographic scan methodology on setup verification and adaptive dose calculation in helical TomoTherapy.
Zhu J; Bai T; Gu J; Sun Z; Wei Y; Li B; Yin Y
Radiat Oncol; 2018 Apr; 13(1):80. PubMed ID: 29699582
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated Radiotherapy With Simultaneous-integrated Boost After Breast-conserving Surgery Compared to Standard Boost-applications Using Helical Tomotherapy With TomoEdge.
Zwicker F; Hoefel S; Kirchner C; Huber PE; Debus J; Schempp M
Anticancer Res; 2021 Apr; 41(4):1909-1920. PubMed ID: 33813396
[TBL] [Abstract][Full Text] [Related]
13. A practical EPR dosimetry system for routine use in radiotherapy: uncertainty analysis of lithium formate dosimeters at the therapeutic dose level.
Höfel S; Stehle M; Zwicker F; Fix MK; Drescher M
Phys Med Biol; 2021 Feb; 66(4):045005. PubMed ID: 32422627
[TBL] [Abstract][Full Text] [Related]
14. Feasibility study of entrance and exit dose measurements at the contra lateral breast with alanine/electron spin resonance dosimetry in volumetric modulated radiotherapy of breast cancer.
Wagner DM; Hüttenrauch P; Anton M; von Voigts-Rhetz P; Zink K; Wolff HA
Phys Med Biol; 2017 Jul; 62(13):5462-5472. PubMed ID: 28436921
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of determining external beam radiotherapy dose using LuSy dosimeter.
Wahabi JM; Wong JHD; Mahdiraji GA; Ung NM
J Appl Clin Med Phys; 2024 Jun; 25(6):e14387. PubMed ID: 38778567
[TBL] [Abstract][Full Text] [Related]
16. Setup uncertainties and the optimal imaging schedule in the prone position whole breast radiotherapy.
Yao S; Zhang Y; Nie K; Liu B; Haffty BG; Ohri N; Yue NJ
Radiat Oncol; 2019 May; 14(1):76. PubMed ID: 31072388
[TBL] [Abstract][Full Text] [Related]
17. Lithium formate EPR dosimetry for verifications of planned dose distributions prior to intensity-modulated radiation therapy.
Gustafsson H; Lund E; Olsson S
Phys Med Biol; 2008 Sep; 53(17):4667-82. PubMed ID: 18695299
[TBL] [Abstract][Full Text] [Related]
18. END-TO-END AUDIT: COMPARISON OF TLD AND LITHIUM FORMATE EPR DOSIMETRY.
Adolfsson E; Wesolowska P; Izewska J; Lund E; Tedgren ÅC
Radiat Prot Dosimetry; 2019 Dec; 186(1):119-122. PubMed ID: 30929009
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of two tomotherapy-based techniques for the delivery of whole-breast intensity-modulated radiation therapy.
Gonzalez VJ; Buchholz DJ; Langen KM; Olivera GH; Chauhan B; Meeks SL; Ruchala KJ; Haimerl J; Lu W; Kupelian PA
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):284-90. PubMed ID: 16618583
[TBL] [Abstract][Full Text] [Related]
20. Helical tomotherapy superficial dose measurements.
Ramsey CR; Seibert RM; Robison B; Mitchell M
Med Phys; 2007 Aug; 34(8):3286-93. PubMed ID: 17879792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
